Taken together, circ-ITCH impeded cell proliferation, invasion and glycolysis by regulating the miR-106a/CDH1 axis, which was in agreement with previous reports that circ-ITCH retarded ovarian carcinoma progress by targeting the miR-145/RASA1 axis [35]. This evidence concerns the gene RASA1 and ovarian carcinoma.